Shenzhen Mindray Bio-Medical Electronics Co., Ltd. Website

Shenzhen Mindray Bio-Medical Electronics Co., Ltd.

SZSE-300760

Company Overview

Shenzhen Mindray Bio-Medical Electronics Co., Ltd. provides medical devices and solutions worldwide. The company offers patient monitoring and life support products, such as patient monitoring systems, electrocardiographs, defibrillators, anesthesia machines, ventilators, infusion pumps, surgical lights, operating tables, medical supply units, endoscopes, and accessories, as well as emergency care, peri-operative care, critical care, and IT solutions. It also provides in-vitro diagnostics products, including hematology and chemistry analyzers and reagents, chemiluminescence immunoassay products, hemoglobin systems, flow cytometry products, and micro plate readers and washers, as well as coagulation, urinalysis, and microbiology solutions; medical imaging systems comprising ultrasound and radiology products; and veterinary products. The company was founded in 1991 and is headquartered in Shenzhen, the People's Republic of China.

  • Name

    Shenzhen Mindray Bio-Medical Electronics Co., Ltd.

  • CEO

    Mr. Hao Wu

  • Website

    www.mindray.com

  • Sector

    Health Care Equipment and Supplies

  • Year Founded

    1991

Profile

  • Market Cap

    CN¥280.18B

  • EV

    CN¥264.5B

  • Shares Out

    1,209.39M

  • Revenue

    CN¥36.99B

  • Employees

    18,044

Margins

  • Gross

    65.77%

  • EBITDA

    39.46%

  • Operating

    36.72%

  • Pre-Tax

    38.51%

  • Net

    34.34%

  • FCF

    33.9%

Returns (5Yr Avg)

  • ROA

    23.1%

  • ROTA

    34.71%

  • ROE

    32.59%

  • ROCE

    32.45%

  • ROIC

    47.51%

Valuation (TTM)

  • P/E

  • P/B

  • EV/Sales

  • EV/EBITDA

  • P/FCF

  • EV/Gross Profit

Valuation (NTM)

  • Price Target

    CN¥365.9

  • P/E

  • PEG

  • EV/Sales

  • EV/EBITDA

  • P/FCF

Financial Health

  • Cash

    CN¥20.79B

  • Net Debt

    -CN¥20.49B

  • Debt/Equity

    0.01

  • EBIT/Interest

    819.06

Growth (CAGR)

  • Rev 3Yr

    16.75%

  • Rev 5Yr

    19.54%

  • Rev 10Yr

  • Dil EPS 3Yr

    19.07%

  • Dil EPS 5Yr

    23.89%

  • Dil EPS 10Yr

  • Rev Fwd 2Yr

    18.01%

  • EBITDA Fwd 2Yr

    16.06%

  • EPS Fwd 2Yr

    19.06%

  • EPS LT Growth Est

    16.51%

Dividends

  • Yield

  • Payout

    53.03%

  • DPS

    CN¥5.56

  • DPS Growth 3Yr

    30.53%

  • DPS Growth 5Yr

    40.93%

  • DPS Growth 10Yr

  • DPS Growth Fwd 2Yr

    132.97%

SZSE:300760